
Our Services
What we provide
We offer deep expertise across the preclinical drug development spectrum, including:
Strategic Program Development – Target selection, pipeline development, experimental workflows, and iterative program development.
Business Development & Licensing – Search and evaluation, competitive intelligence, due diligence, deal strategy, and partnership facilitation.
R&D Strategy & Execution – Proof of concept studies, experimental design, mechanism-of-action deconvolution, ADMET studies, formulation, biomarker studies, and program management.
Cross-Functional Leadership – Coordination and communication between interdisciplinary teams, international R&D and CRO partnerships across the U.S., EU, and Asia.
Competitive Intelligence & Market Insight
At Fulgurite AB, we transform raw information into actionable strategy. Our competitive intelligence services provide a clear view of the therapeutic landscape, helping you anticipate market shifts, identify white space, and position your programs for success. We go beyond surface-level analysis—integrating scientific, clinical, and commercial perspectives to deliver insights that drive decision-making.
Our Competitive Intelligence Approach
Landscape Mapping – Comprehensive tracking of competitor pipelines, mechanisms, modalities, and trial progress.
Opportunity & Threat Analysis – Identifying gaps, emerging entrants, and disruptive technologies that could impact your market.
Clinical Benchmarking – Comparative analysis of efficacy, safety, and differentiation potential.
Deal & Partnership Monitoring – Real-time tracking of licensing, M&A, and strategic collaborations across the sector.